Mdm2 promotes the rapid degradation of p53

Haupt, Ygal, Maya, Ruth, Kazaz, Anat, Oren, Moshe·1997·Nature

Cited by (1,058)

Items 301–400 of 1,058

  1. Terphenyl‐Based Helical Mimetics That Disrupt the p53/HDM2 Interaction
    Hang Hubert Yin, Gui‐in Lee, Hyung Soon Park, Gregory A. Payne, Johanna M. Rodriguez, Saı̈d M. Sebti, Andrew D. Hamilton · 2005 · Angewandte Chemie International Edition
  2. Smoking, p53 Mutation, and Lung Cancer
    Gibbons, Don L., Byers, Lauren A., Kurie, Jonathan M. · 2014 · Molecular Cancer Research
  3. MDM2 Is a Negative Regulator of p21 , Independent of p53
    Zhuo Zhang, Hui Wang, M. Li, Sudhir Agrawal, Xinbin Chen, Ruiwen Zhang · 2004 · Journal of Biological Chemistry
  4. The mechanism of AH receptor protein down-regulation (degradation) and its impact on AH receptor-mediated gene regulation
    Richard S. Pollenz · 2002 · Chemico-Biological Interactions
  5. PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes
    Susana Velasco-Miguel, Leonard Buckbinder, Patrice Jean, Larry Gelbert, Randy L. Talbott, Jana L. Laidlaw, Bernd R. Seizinger, Nikolai Kley · 1999 · Oncogene
  6. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination
    Giovanna Benvenuto, Shaowei Li, Samantha J Brown, Richard Braverman, William C. Vass, Jeremy P. Cheadle, Dicky J.J. Halley, Julian R. Sampson, Ralf Wienecke, Jeffrey E. DeClue · 2000 · Oncogene
  7. ATM, a central controller of cellular responses to DNA damage
    Kum Kum Khanna, Martin Francis Lavin, Stephen P. Jackson, Terrence D. Mulhern · 2001 · Cell Death and Differentiation
  8. p53 transcriptional activity is essential for p53‐dependent apoptosis following DNA damage
    Connie Chao, Shinichi Saito, Jian Kang, Carl W. Anderson, Ettore Appella, Yang Xu · 2000 · The EMBO Journal
  9. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo
    Carol Midgley, Joana M. P. Desterro, Mark K. Saville, Stephanie F. Howard, Alison Sparks, Ronald T. Hay, David Philip Lane · 2000 · Oncogene
  10. Structural Basis of Competitive Recognition of p53 and MDM2 by HAUSP/USP7: Implications for the Regulation of the p53–MDM2 Pathway
    Hu, Min, Gu, Lichuan, Li, Muyang, Jeffrey, Philip D, Gu, Wei, Shi, Yigong · 2006 · PLoS Biology
  11. Targeting p53 for Novel Anticancer Therapy
    Zhen Wang, Yi Sun · 2010 · Translational Oncology
  12. Regulation of apoptosis: the ubiquitous way
    Yili Yang, YU Xiao-dan · 2003 · The FASEB Journal
  13. Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia
    Carvajal, Luis A., Neriah, Daniela Ben, Senecal, Adrien, Benard, Lumie, Thiruthuvanathan, Victor, Yatsenko, Tatyana, Narayanagari, Swathi-Rao, Wheat, Justin C., Todorova, Tihomira I., Mitchell, Kelly et al. · 2018 · Science Translational Medicine
  14. The nucleolus: an emerging target for cancer therapy
    Nadine Hein, Katherine M. Hannan, Amee J. George, Elaine Sanij, Ross D. Hannan · 2013 · Trends in Molecular Medicine
  15. Modulation of transcription factor function by O-GlcNAc modification
    Sabire Özcan, Sreenath S. Andrali, Jamie E.L. Cantrell · 2010 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  16. HIF-1: Using Two Hands to Flip the Angiogenic Switch
    Gregg L. Semenza · 2000 · Cancer and Metastasis Reviews
  17. Essential role of ribosomal protein L11 in mediating growth inhibition‐induced p53 activation
    Krishna Bhat, Koji Itahana, Aiwen Jin, Yanping Zhang · 2004 · The EMBO Journal
  18. Discovery of Potent Antagonists of the Interaction between Human Double Minute 2 and Tumor Suppressor p53
    Carlos Garcı́a-Echeverrı́a, Patrick Chêne, Marcel J. J. Blommers, Pascal Furet · 2000 · Journal of Medicinal Chemistry
  19. Akt-Mediated Cisplatin Resistance in Ovarian Cancer: Modulation of p53 Action on Caspase-Dependent Mitochondrial Death Pathway
    Xiaokui Yang, Michael E. Fraser, Ute Martha Moll, Ajoy Basak, Benjamin K. Tsang · 2006 · Cancer Research
  20. Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation
    Itahana, Koji, Mao, Hua, Jin, Aiwen, Itahana, Yoko, Clegg, Hilary V., Lindström, Mikael S., Bhat, Krishna P., Godfrey, Virginia L., Evan, Gerard I., Zhang, Yanping · 2007 · Cancer Cell
  21. The Role of MDM2 Amplification and Overexpression in Tumorigenesis
    Oliner, Jonathan D., Saiki, Anne Y., Caenepeel, Sean · 2016 · Cold Spring Harbor Perspectives in Medicine
  22. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
    Anne-Marie F. van der Kevie-Kersemaekers, Gertjan J. Fleuren, Gemma G. Kenter, Lambert J. C. M. Van den Broek, Sandra M. Kolkman-Uljee, J. Hermans, Marc J. van de Vijver · 1999 · PubMed
  23. Regulation of Apoptosis and Differentiation by p53 in Human Embryonic Stem Cells
    Han Qin, Tianxin Yu, Tingting Qing, Yanxia Liu, Yang Zhao, Jun Cai, Jian Li, Zhihua Song, Xiuxia Qu, Peng Zhou et al. · 2006 · Journal of Biological Chemistry
  24. p53 and ribosome biogenesis stress: The essentials
    Lior Golomb, Siniša Volarević, Moshe Oren · 2014 · FEBS Letters
  25. The Ribosome Biogenesis—Cancer Connection
    Penzo, Marianna, Montanaro, Lorenzo, Treré, Davide, Derenzini, Massimo · 2019 · Cells
  26. C-Terminal Ubiquitination of p53 Contributes to Nuclear Export
    Marion A. E. Lohrum, Douglas B. Woods, Robert L. Ludwig, Éva Bálint, Karen H. Vousden · 2001 · Molecular and Cellular Biology
  27. p53 mRNA controls p53 activity by managing Mdm2 functions
    Marco M. Candeias, Laurence Malbert-Colas, Darren J. Powell, Chrysoula Daskalogianni, Magdalena M. Maslon, Nadia Naski, Karima Bourougaa, Fabien M. Calvo, Robin Fåhræus · 2008 · Nature Cell Biology
  28. ERK-1/2 and p38 Kinase Oppositely Regulate Nitric Oxide-induced Apoptosis of Chondrocytes in Association with p53, Caspase-3, and Differentiation Status
    Song Ja Kim, Jung‐Won Ju, Chun‐do Oh, Young‐Mee Yoon, Woo Keun Song, Jae‐Hong Kim, Yung Joon Yoo, Ok‐Sun Bang, Shin‐Sung Kang, Jang‐Soo Chun · 2002 · Journal of Biological Chemistry
  29. Antioxidants, reactive oxygen and nitrogen species, gene induction and mitochondrial function
    Malcolm Joseph Jackson · 2002 · Molecular Aspects of Medicine
  30. Excess β‐catenin promotes accumulation of transcriptionally active p53
    Alexander Damalas, Avri Ben‐Ze'ev, Inbal Simcha, Michael S. Shtutman, Juan Fernando Martínez-Leal, Jacob Zhurinsky, Benjamin Geiger, Moshe Oren · 1999 · The EMBO Journal
  31. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3‐only Bcl‐2 family member Bim
    T. Akiyama, Philippe Bouillet, Tsuyoshi Miyazaki, Yuho Kadono, Hirotaka Chikuda, Ung‐il Chung, Akira Fukuda, Atsuhiko Hikita, Hiroaki Seto, Takashi Okada et al. · 2003 · The EMBO Journal
  32. Control of the cell cycle and apoptosis
    Ante S. Lundberg, Robert A. Weinberg · 1999 · European Journal of Cancer
  33. E4F1 Is an Atypical Ubiquitin Ligase that Modulates p53 Effector Functions Independently of Degradation
    Laurent Le Cam, Laetitia Karine Linares, Conception Paul, Eric Julien, Matthieu Lacroix, Elodie Hatchi, Robinson Triboulet, Guillaume Bossis, Ayelet Shmueli, Manuel S. Rodríguez et al. · 2006 · Cell
  34. Critical role for Daxx in regulating Mdm2
    Jun Tang, Like Qu, Jianke Zhang, Wenge Wang, Jennifer S. Michaelson, Yan Degenhardt, Wafik S. El‐Deiry, Xiaolu Yang · 2006 · Nature Cell Biology
  35. Mdm2 Regulates p53 mRNA Translation through Inhibitory Interactions with Ribosomal Protein L26
    Yaara Ofir-Rosenfeld, Kristy Boggs, Dan Michael, Michael B. Kastan, Moshe Oren · 2008 · Molecular Cell
  36. Inhibition of NF‐κB cellular function via specific targeting of the IκB‐ubiquitin ligase
    Avraham Yaron, Hedva Gonen, Irit Alkalay, Ada Hatzubai, Steffen Jung, Shaul Beyth, Frank Mercurio, Anthony M. Manning, Aaron J. Ciechanover, Yinon Ben‐Neriah · 1997 · The EMBO Journal
  37. <i>mdm2</i> Is Critical for Inhibition of p53 during Lymphopoiesis and the Response to Ionizing Irradiation
    Mendrysa, Susan M., McElwee, Matthew K., Michalowski, Jennifer, O'Leary, Kathleen A., Young, Karen M., Perry, Mary Ellen · 2003 · Molecular and Cellular Biology
  38. Functional Analysis of the Roles of Posttranslational Modifications at the p53 C Terminus in Regulating p53 Stability and Activity
    Feng, Lijin, Lin, Tongxiang, Uranishi, Hiroaki, Gu, Wei, Xu, Yang · 2005 · Molecular and Cellular Biology
  39. Mechanisms of switching on p53: a role for covalent modification?
    David W. Meek · 1999 · Oncogene
  40. Role of p53 in breast cancer progression: An insight into p53 targeted therapy
    Charlie Marvalim, Arpita Datta, Soo Chin Lee · 2023 · Theranostics
  41. Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs
    Mikhail V. Blagosklonny · 2002 · Leukemia
  42. STAT-1 Interacts with p53 to Enhance DNA Damage-induced Apoptosis
    Paul A. Townsend, Tiziano Maria Scarabelli, Sean M. Davidson, Richard A. Knight, David S. Latchman, Anastasis Stephanou · 2004 · Journal of Biological Chemistry
  43. Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms
    Stad, Robert, Little, Natalie A, Xirodimas, Dimitris P, Frenk, Ruth, van der Eb, Alex J, Lane, David P, Saville, Mark K, Jochemsen, Aart G · 2001 · The EMBO Reports
  44. G1 tetraploidy checkpoint and the suppression of tumorigenesis
    Robert L. Margolis, Olivier D. Lohez, Paul R. Andreassen · 2002 · Journal of Cellular Biochemistry
  45. Structures of low molecular weight inhibitors bound to MDMX and MDM2 reveal new approaches for p53-MDMX/MDM2 antagonist drug discovery
    Grzegorz M. Popowicz, Anna Czarna, Siglinde Wolf, Kan Wang, Wei Wang, Alexander S. S. Dömling, Tad A. Holak · 2010 · Cell Cycle
  46. p53-Mdm2--the affair that never ends
    Dania Alarcon-Vargas · 2002 · Carcinogenesis
  47. Activation of p53 in cervical carcinoma cells by small molecules
    Sakari Hietanen, Sonia Laı́n, Eberhard Krausz, Christine Blattner, David Philip Lane · 2000 · Proceedings of the National Academy of Sciences
  48. Apoptosis: why and how does it occur in biology?
    Engı̇n Ulukaya, Ceyda Açılan, Yusuf Nadir Yilmaz · 2011 · Cell Biochemistry and Function
  49. The N-terminal Domain of p53 is Natively Unfolded
    Roger J. P. Dawson, Lin Müller, Alexander Dehner, Christian Klein, Horst Kessler, Johannes Büchner · 2003 · Journal of Molecular Biology
  50. ASPP1 and ASPP2: Common Activators of p53 Family Members
    Daniele Bergamaschi, Yardena Samuels, Boquan Jin, Sai Duraisingham, Tim Crook, Xin Lü · 2004 · Molecular and Cellular Biology
  51. D-peptide inhibitors of the p53–MDM2 interaction for targeted molecular therapy of malignant neoplasms
    Min Liu, Chong Li, Marzena Pazgier, Changqing Li, Yubin Mao, Yifan Lv, Bing Gu, Gang Wei, Weirong Yuan, Changyou Zhan et al. · 2010 · Proceedings of the National Academy of Sciences
  52. Role of Pin1 in the Regulation of p53 Stability and p21 Transactivation, and Cell Cycle Checkpoints in Response to DNA Damage
    Gerburg M. Wulf, Yih‐Cherng Liou, Akihide Ryo, Sam W. Lee, Kun Ping Lu · 2002 · Journal of Biological Chemistry
  53. MDMX: from bench to bedside
    Marine, Jean-Christophe W., Dyer, Michael A., Jochemsen, Aart G. · 2007 · Journal of Cell Science
  54. aHIF: a Natural Antisense Transcript Overexpressed in Human Renal Cancer and During Hypoxia
    Catherine Thrash-Bingham, Kenneth D. Tartof · 1999 · JNCI Journal of the National Cancer Institute
  55. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer
    Hirotaka Osada, Takashi Takahashi · 2002 · Oncogene
  56. Ribosomal Proteins and Human Diseases: Pathogenesis, Molecular Mechanisms, and Therapeutic Implications
    Wei Wang, Subhasree Ashok Nag, Xu Zhang, Ming‐Hai Wang, Hui Wang, Jianwei Zhou, Ruiwen Zhang · 2014 · Medicinal Research Reviews
  57. Role of E2F in cell cycle control and cancer
    David G. Johnson · 1998 · Frontiers in bioscience
  58. MAP Kinases and Hypoxia in the Control of VEGF Expression
    Edurne Berra, Gilles Pagès, Jacques Pouysségur · 2000 · Cancer and Metastasis Reviews
  59. Reciprocal repression between P53 and TCTP
    Robert B. Amson, Salvatore Pece, Alexandra Lespagnol, Rajesh Vyas, Giovanni Mazzarol, Daniela Tosoni, Ivan Nicola Colaluca, Giuseppe Viale, Sylvie Rodrigues-Ferreira, Jessika Wynendaele et al. · 2011 · Nature Medicine
  60. Ubiquitination and Degradation of Mutant p53
    Lukashchuk, Natalia, Vousden, Karen H. · 2007 · Molecular and Cellular Biology
  61. Nutlin-3a Activates p53 to Both Down-regulate Inhibitor of Growth 2 and Up-regulate mir-34a, mir-34b, and mir-34c Expression, and Induce Senescence
    Kensuke Kumamoto, Elisa A. Spillare, Kaori Fujita, Izumi Horikawa, Taro Yamashita, Ettore Appella, Makoto Nagashima, Seiichi Takenoshita, Jun Yokota, Curtis C. Harris · 2008 · Cancer Research
  62. p53 family update: p73 and p63 develop their own identities.
    Meredith S. Irwin, William G. Kaelin · 2001 · PubMed
  63. Dial 9-1-1 for p53: Mechanisms of p53 Activation by Cellular Stress
    Mats E. Ljungman · 2000 · Neoplasia
  64. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1
    Gad Asher, Joseph Lotem, Leo Sachs, Chaim Kahana, Yosef Shaul · 2002 · Proceedings of the National Academy of Sciences
  65. Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice
    Véronique Bouvard, Tatiana Zaitchouk, Monique Vacher, Arlette Duthu, Martine Canivet, Caroline Choisy, Myriam Nieruchalski, Evelyne May · 2000 · Oncogene
  66. DJ-1 Decreases Bax Expression through Repressing p53 Transcriptional Activity
    Jun Yan Fan, Haigang Ren, Nali Jia, Erkang Fei, Tian Gang Zhou, Peng Jiang, Mian Wu, Guanghui Wang · 2007 · Journal of Biological Chemistry
  67. Mast cell tryptase does not alter matrix metalloproteinase expression in human dermal fibroblasts: Further evidence that proteolytically-active tryptase is a potent fibrogenic factor
    Jianhua Zhang, Barry L. Gruber, Mary J. Marchese, Stanley Zucker, Lawrence B. Schwartz, Richard R. Kew · 1999 · Journal of Cellular Physiology
  68. A Novel Cofactor for p300 that Regulates the p53 Response
    Noriko Shikama, Chang‐Woo Lee, Stephen France, Laurent Delavaine, Jonathan J. Lyon, Marija Krstic–Demonacos, Nicholas Barrie La Thangue · 1999 · Molecular Cell
  69. Regulation of p53 localization
    Shun‐Hsin Liang, Michael F. Clarke · 2001 · European Journal of Biochemistry
  70. BCR/ABL activates mdm2 mRNA translation via the La antigen
    Rossana Trotta, Tatiana Vignudelli, Olivia Candini, Robert V. A. Intine, Luisa Pecorari, Clara Guerzoni, Giorgia Santilli, Mike Byrom, Silvia Goldoni, Lance P. Ford et al. · 2003 · Cancer Cell
  71. Impaired ribosome biogenesis: mechanisms and relevance to cancer and aging
    Zsofia Turi, Matthew Lacey, Martin Mistrík, Pavel Moudrý · 2019 · Aging
  72. The ubiquitin-proteasome pathway in cancer
    Vito J. Spataro, Chris J. Norbury, Adrian Llewellyn Harris · 1998 · British Journal of Cancer
  73. p53 and the pathogenesis of skin cancer
    Cara L. Benjamin, Honavara N. Ananthaswamy · 2006 · Toxicology and Applied Pharmacology
  74. Dual Roles of MDM2 in the Regulation of p53: Ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 Activity
    D. Shi, Wei Jun Gu · 2012 · Genes & Cancer
  75. Cyclin G Recruits PP2A to Dephosphorylate Mdm2
    Okamoto, Koji, Li, Hongyun, Jensen, Michael R, Zhang, Tingting, Taya, Yoichi, Thorgeirsson, Snorri S, Prives, Carol · 2002 · Molecular Cell
  76. Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination
    Chunhong Yan, Dan Lü, Tsonwin Hai, Douglas D. Boyd · 2005 · The EMBO Journal
  77. Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo
    Mikhail Doubrovin, Vladimir Ponomarev, Tatiana Beresten, Julius Balatoni, William G. Bornmann, Ronald D. Finn, John Laurence Humm, Steven M. Larson, Michel Sadelain, Ronald G. Blasberg et al. · 2001 · Proceedings of the National Academy of Sciences
  78. MDM2 Promotes Cell Motility and Invasiveness by Regulating E-Cadherin Degradation
    Yang, Jer-Yen, Zong, Cong S., Xia, Weiya, Wei, Yongkun, Ali-Seyed, Mohamed, Li, Zheng, Broglio, Kristine, Berry, Donald A., Hung, Mien-Chie · 2006 · Molecular and Cellular Biology
  79. Transcription Factor E2F-1 Is Upregulated in Response to DNA Damage in a Manner Analogous to That of p53
    Christine Blattner, Alison Sparks, David Philip Lane · 1999 · Molecular and Cellular Biology
  80. MdmX Protects p53 from Mdm2-Mediated Degradation
    Jackson, Mark W., Berberich, Steven J. · 2000 · Molecular and Cellular Biology
  81. Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease
    Cristine Alvès da Costa, Claire Sunyach, Emilie Giaime, Andrew B. West, Olga Corti, Alexis Brice, Stephen H Safe, Patrick M. Abou‐Sleiman, Nicholas William Wood, Hitoshi Takahashi et al. · 2009 · Nature Cell Biology
  82. Evaluating and responding to mitochondrial dysfunction: the mitochondrial unfolded-protein response and beyond
    Cole M. Haynes, Christopher J. Fiorese, Yifan Lin · 2013 · Trends in Cell Biology
  83. Mdm2 binds p73α without targeting degradation
    Bálint, Eva, Bates, Stewart, Vousden, Karen H · 1999 · Oncogene
  84. 14-3-3 Proteins Regulate Intracellular Localization of the bZIP Transcriptional Activator RSG
    Daisuke Igarashi, Sarahmi Ishida, Jutarou Fukazawa, Yohsuke Takahashi · 2001 · The Plant Cell
  85. p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PL pro via E3 ubiquitin ligase RCHY1
    Yue Ma‐Lauer, Javier Carbajo-Lozoya, Marco Y. Hein, Marcel A. Müller, Wen Deng, Jian Lei, Benjamin Meyer, Yuri Kusov, Brigitte von Brunn, Dev Raj Bairad et al. · 2016 · Proceedings of the National Academy of Sciences
  86. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress
    Eva Camilla Gronroos, Alexey A. Terentiev, Tanel Punga, Johan Ericsson · 2004 · Proceedings of the National Academy of Sciences
  87. Liposarcoma: Molecular Genetics and Therapeutics
    Rachel K. Conyers, Sophie Young, David Morgan Thomas · 2010 · Sarcoma
  88. Porcine milk-derived exosomes promote proliferation of intestinal epithelial cells
    Ting Chen, Mei-Ying Xie, Jiajie Sun, Rui-Song Ye, Xiao Ling Cheng, Rui-Ping Sun, Li-Min Wei, Meng Li, Delin Lin, Qingyan Jiang et al. · 2016 · Scientific Reports
  89. The hybridoma revolution: an offshoot of basic research
    César Milstein · 1999 · BioEssays
  90. Toxicity Testing in the 21st Century: Defining New Risk Assessment Approaches Based on Perturbation of Intracellular Toxicity Pathways
    Sudin Bhattacharya, Qiang Zhang, Paul Lawford Carmichael, Kim Boekelheide, Melvin E. Andersen · 2011 · PLoS ONE
  91. Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells
    Arnd Hengstermann, Laetitia Karine Linares, Aaron J. Ciechanover, Noel J. Whitaker, Martin Scheffner · 2001 · Proceedings of the National Academy of Sciences
  92. MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer
    Seong O Suh, Yi Chen, Mohd Saif Zaman, Hiroshi Hirata, Soichiro Yamamura, Varahram Shahryari, Jan Liu, Z. Laura Tabatabai, Sanjay Kakar, Guoren Deng et al. · 2011 · Carcinogenesis
  93. TP53 family members and human cancers
    Jean Bénard, Sétha Douc‐Rasy, Jean‐Charles Ahomadegbe · 2003 · Human Mutation
  94. The Physical Association of Multiple Molecular Chaperone Proteins with Mutant p53 Is Altered by Geldanamycin, an hsp90-Binding Agent
    Luke J. Whitesell, Patrick D. Sutphin, Elizabeth J. Pulcini, Jesse D. Martinez, Paul H. Cook · 1998 · Molecular and Cellular Biology
  95. MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation
    Jin, Yetao, Lee, Hunjoo, Zeng, Shelya X., Dai, Mu‐Shui, Lu, Hua · 2003 · The EMBO Journal
  96. E3 Ubiquitin Ligases as Cancer Targets and Biomarkers
    Yi Sun · 2006 · Neoplasia
  97. Phosphorylation by Casein Kinase I Promotes the Turnover of the Mdm2 Oncoprotein via the SCFβ-TRCP Ubiquitin Ligase
    Hiroyuki Inuzuka, Alan Tseng, Daming Gao, Bo Zhai, Qing Hua Zhang, Shavali Shaik, Lixin Wan, Xiaolu A. Cambronne, Caroline S. Mock, Haoqiang Yin et al. · 2010 · Cancer Cell
  98. The role of p53 in hypoxia-induced apoptosis
    Ester M. Hammond, Amato J. Giaccia · 2005 · Biochemical and Biophysical Research Communications
  99. Chaperone-mediated autophagy degrades mutant p53
    Helin Vakifahmetoglu-Norberg, Minsu Kim, Hongguang Xia, Marcin Iwanicki, Dimitry Ofengeim, Jonathan L. Coloff, Lifeng Pan, Tan A. Ince, Guido Kroemer, Joan S. Brugge et al. · 2013 · Genes & Development
  100. Inhibition of Crm1–p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation
    Masayuki Kanai, Kazuhiko Hanashiro, Song‐Hee Kim, Shuji Hanai, A. Hamid Boulares, Masanao Miwa, Kenji Fukasawa · 2007 · Nature Cell Biology